These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 3190191)
1. Concentrations of erythromycin, 2'-acetyl erythromycin, and their anhydro forms in plasma and tonsillar tissue after repeated dosage of erythromycin stearate and erythromycin acistrate. Gordin A; Männistö PT; Antikainen R; Savolainen S; Ylikoski J; Kokkonen P; Rauramaa V Antimicrob Agents Chemother; 1988 Jul; 32(7):1019-24. PubMed ID: 3190191 [TBL] [Abstract][Full Text] [Related]
2. Tonsillar penetration of erythromycin and its 2'-acetyl ester in patients with chronic tonsillitis. Savolainen S; Männistö PT; Gordin A; Antikainen R; Haataja H; Tuominen RK; Ylikoski J J Antimicrob Chemother; 1988 Jun; 21 Suppl D():73-84. PubMed ID: 3391878 [TBL] [Abstract][Full Text] [Related]
3. Penetration of erythromycin into periapical lesions after repeated doses of erythromycin acistrate and erythromycin stearate: a pilot study. Tuominen RK; Lehtinen R; Peltola J; Wikberg R; Gordin A; Kokkonen P; Pohto P Oral Surg Oral Med Oral Pathol; 1991 Jun; 71(6):684-8. PubMed ID: 2062521 [TBL] [Abstract][Full Text] [Related]
4. Erythromycin and 2'-acetyl erythromycin concentrations in plasma and pelvic tissues after repeated doses of erythromycin acistrate. Lehtonen L; Wikberg R; Karhunen M; Kokkonen P; Tuominen R Arzneimittelforschung; 1993 Jan; 43(1):53-6. PubMed ID: 8447849 [TBL] [Abstract][Full Text] [Related]
5. Antibiotic concentration in suction skin blister fluid and saliva after repeated dosage of erythromycin acistrate and erythromycin base. Tuominen RK; Männistö PT; Solkinen A; Vuorela A; Pohto P; Haataja H J Antimicrob Chemother; 1988 Jun; 21 Suppl D():57-65. PubMed ID: 3391876 [TBL] [Abstract][Full Text] [Related]
6. Fate of single oral doses of erythromycin acistrate, erythromycin stearate and pelleted erythromycin base analysed by mass-spectrometry in plasma of healthy human volunteers. Männistö PT; Taskinen J; Ottoila P; Solkinen A; Vuorela A; Nykänen S J Antimicrob Chemother; 1988 Jun; 21 Suppl D():33-43. PubMed ID: 3391874 [TBL] [Abstract][Full Text] [Related]
7. Concentrations of azithromycin in human tonsillar tissue. Foulds G; Chan KH; Johnson JT; Shepard RM; Johnson RB Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):853-6. PubMed ID: 1662631 [TBL] [Abstract][Full Text] [Related]
8. Penetration of erythromycin into tonsillar tissue. Falchi M; Teodori F; Carraro A; Cioce C; Scaglione F; Braga PC; Fraschini F Curr Med Res Opin; 1985; 9(9):611-5. PubMed ID: 4053675 [TBL] [Abstract][Full Text] [Related]
9. Time course of the antibacterial activity of erythromycin stearate and erythromycin acistrate against two Staphylococcus aureus strains in vitro. Korkeala H; Männistö PT J Antimicrob Chemother; 1988 Aug; 22(2):127-33. PubMed ID: 3182415 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of erythromycin acistrate (2'-acetyl erythromycin stearate) and erythromycin stearate in experimental infections in mice. Männistö PT; Hanhijärvi H; Havas A; Vuorela A; Komulainen H; Rauramaa V J Pharmacol Exp Ther; 1989 Sep; 250(3):1028-33. PubMed ID: 2778707 [TBL] [Abstract][Full Text] [Related]
11. Tonsillar tissue penetration of dirithromycin after multiple doses. Benson JM; Arnold J; Manning SC; Coleman DL; Sides GD; Conforti PM; Lemon E; Watkins VS J Clin Pharmacol; 1996 Sep; 36(9):832-7. PubMed ID: 8889904 [TBL] [Abstract][Full Text] [Related]
12. Concentrations of flurithromycin in serum and tonsils. Galioto GB; Mevio E; Galioto P; Zanuso G; Lepore AM Int J Clin Pharmacol Ther Toxicol; 1989 Mar; 27(3):126-8. PubMed ID: 2722307 [TBL] [Abstract][Full Text] [Related]
13. Comparative liver toxicity of various erythromycin derivatives in animals. Viluksela M; Hanhijärvi H; Husband RF; Kosma VM; Collan Y; Männistö PT J Antimicrob Chemother; 1988 Jun; 21 Suppl D():9-27. PubMed ID: 3391880 [TBL] [Abstract][Full Text] [Related]
14. Effect of food on absorption and hydrolysis of erythromycin acistrate. Järvinen A; Nykänen S; Mattila J; Haataja H Arzneimittelforschung; 1992 Jan; 42(1):73-6. PubMed ID: 1586385 [TBL] [Abstract][Full Text] [Related]
15. Erythromycin acistrate and erythromycin stearate in the treatment of non-gonococcal urethritis. Rostila T; Visa K; Gordin A; Antikainen R J Antimicrob Chemother; 1988 Jun; 21 Suppl D():113-9. PubMed ID: 3391873 [TBL] [Abstract][Full Text] [Related]
16. The penetration of erythromycin into Waldeyer's ring--tonsil and adenoid tissue. Sundberg L; Edén T; Ernstson S Infection; 1982; 10 Suppl 2():S105-7. PubMed ID: 6980840 [TBL] [Abstract][Full Text] [Related]
17. Tissue distribution of dirithromycin: comparison with erythromycin. Bergogne-Bérézin E J Antimicrob Chemother; 1993 Mar; 31 Suppl C():77-87. PubMed ID: 8478314 [TBL] [Abstract][Full Text] [Related]
18. Bioavailability of erythromycin acistrate from hard gelatin capsules containing sodium bicarbonate. Marvola M; Nykänen S; Nokelainen M Pharm Res; 1991 Aug; 8(8):1056-8. PubMed ID: 1656422 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of erythromycin acistrate and erythromycin stearate in acute skin infections of patients with atopic eczema. Salo OP; Gordin A; Brandt H; Antikainen R J Antimicrob Chemother; 1988 Jun; 21 Suppl D():101-6. PubMed ID: 3391871 [TBL] [Abstract][Full Text] [Related]
20. The influence of food on the bioavailability of new formulations of erythromycin stearate and base. Rutland J; Berend N; Marlin GE Br J Clin Pharmacol; 1979 Oct; 8(4):343-7. PubMed ID: 508509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]